It is important to incentivize new therapies so companies will invest and bring products to market. Kathy Lester, JD, MPH, talks with Lori about how Medicare is working to create policies to spark innovation. About 90 percent of people on dialysis have access to Medicare. But ESRD treatment options only become available when payment is available to support them. When funding is not available, new innovations, even those approved by the FDA, will not become available to patients. Tune in to learn what you can do to ensure we have access to new therapies and medical equipment in the future.
You can also listen to and download the podcast with these apps:
Hosted By Lori Hartwell
Lori Hartwell is the Founder & President of Renal Support Network (RSN) and the host of KidneyTalk®, a radio podcast show. Lori was diagnosed with kidney disease at the age of two. In 1993 she founded RSN to instill “health, happiness and hope” into the lives of those affected by chronic kidney disease. Lori is also the author of the inspirational book Chronically Happy: Joyful Living in Spite of Chronic Illness and is a four-time kidney transplant recipient.
Web ID 3095